Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0025362 (
mental retardation
)
15,878
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Data obtained concerning Hepatitis B as a possible couse of Down's syndrome, neonatal hepatitis, and the occurrence of
Hepatitis A
and B in institutionalized Down's syndrome and matched non-Down's syndrome retarded patients was summarized. The results of our studies indicated that Hepatitis B infection during pregnancy was not related to the genetic changes associated with Down's syndrome. It was further indicated that in institutionalized patients the incidence of Hepatitis B infection in both Down's syndrome and other mentally retarded patients was similar. Within the institition we studied, the incidence of Hepatitis B varied among wards. This ward variation seemed to be related to age at time of institutionalization and degree of
mental retardation
. Those patients with most retardation and those institutionalized at an early age were placed on wards with highest incidence of Hepatitis B antigenemia.
...
PMID:Hepatitis and Down's syndrome. 12 5
Institutionalized patients with Down syndrome and matched controls with other causes of
mental retardation
were tested by immune adherence hemagglutination for the presence of antibody to
hepatitis A
antigen (anti-HA). Altogether 75.1% (175 of 233) exhibited presence of anti-HA, with no differences by sex or age. Patients reactive for hepatitis B surface antigen (HBsAg) or its antibody (anti-HBs) were reactive for anti-HA significantly more frequently than those with a negative reaction for these markers. In contrast to serologic markers of hepatitis type B, prevalence of anti-HA does not depend on the cause of
mental retardation
or on the age at primary infection. The rate of anti-HA positivity was found to be closely correlated with duration of institutionalization. The study confirmed that many closed institutions for the mentally retarded are hyperendemic for hepatitis type A and that formation of anti-HA is not greatly affected by either immune deficiency or immune immaturity.
...
PMID:Antibody to hepatitis A antigen in institutionalized mentally retarded patients. 13 79
The prevalence of antibody to
hepatitis A
virus (anti-HAV) was determined in 854 people living in a large institution for the mentally retarded in Melbourne. Altogether 638 (74.4%) of the subjects were found to have specific antibody detectable by solid-phase radioimmunoassay (SPRIA). No difference in antibody prevalence was observed between males and females; however, the prevalence was higher among subjects with Down syndrome (84.1%) than those of other forms of
mental retardation
(72.8%). In both groups there was an increase in prevalence of antibody with increasing age and duration of institutionalization. When compared with the open community, patients in this institution have a higher prevalence of antibody and appear to acquire their infections at an earlier age.
...
PMID:Prevalence of antibody to the hepatitis A virus in a large institution for the mentally retarded. 21 14
The high incidence of
hepatitis A
and B in institutionalized patients with Down's syndrome is not fully understood. Under poor hygienic conditions immunological alterations might predispose to these infections. To minimize environmental influences, 125 patients with Down's syndrome (mean age 11.9 years) living at home with their families were studied for the occurrence of serological markers of
Hepatitis A
and B. 106 outpatients with
mental retardation
of other genesis (mean age 12.4 years), and 114 consecutive voluntary blood donors (mean age 18.0 years) from the same area served as controls. Evidence of previous
hepatitis A
virus infection was found in 5.6% of Down's patients, in 9.4% of other mentally retarded patients, and in 16.7% of healthy controls. Evidence of previous or ongoing hepatitis B virus infection was a common finding in both groups of
mental retardation
(Down's syndrome 20.0%, other mentally retarded patients 11.3%) in sharp contrast to healthy blood donors (0.9%, p less than 0.05). Patients with Down's syndrome, however, revealed a much higher incidence of HBs-antigenemia as compared with other mentally retarded patients (12.8% vs. 2.8%, p less than 0.01). All HBs antigen-positive cases had normal transaminase levels and no overt clinical signs of liver disease, suggesting an asymptomatic carrier state. These data indicate that
hepatitis A
is not a special risk for mentally retarded outpatients, while hepatitis B virus infection is hyperendemic even in not-institutionalized patients.(ABSTRACT TRUNCATED AT 250 WORDS)
...
PMID:Hepatitis A and B in non-institutionalized mentally retarded patients. 293 80
A 34-month-old girl with Down's syndrome from the Marshall Islands was hospitalized in September, 1981, at Tripler Army Medical Center for evaluation of a heart murmur and definitive repair of an imperforate anus for which she had had a colostomy since birth. She became jaundiced and had serologic evidence of
hepatitis A
infection. Over the next month eight hospital personnel (four nurses, three nursing assistants and one physician) who had had direct contact with the patient became ill with
hepatitis A
. Our patient, like the index cases in five previous reports of nosocomial
hepatitis A
outbreaks, was incontinent of feces. In addition she was hospitalized during the incubation period before clinical illness when virus fecal excretion is likely to be maximal. Patients in the prodromal stage of
hepatitis A
infection who are hospitalized pose a significant risk to exposed hospital staff. This risk is enhanced if there are additional factors present which promote spread of disease by the fecal-oral route such as infancy,
mental retardation
, diarrhea and fecal incontinence.
...
PMID:Hospital outbreak of hepatitis A: risk factors for spread. 623 34
The natural history of
hepatitis A
and B infections in a large institution for the mentally retarded were studied over an eight year period. Serum samples were obtained from most subjects on three occasions and tested for anti-HAV, HBsAg, anti-HBs and occasionally anti-HBc, by solid-phase radioimmunoassay.
Hepatitis A
was found to have been a common infection was 74.8% of subjects having detectable levels of antibody. The virus does not appear to be endemic, as the prevalence of antibody in children admitted since the last outbreak was no higher than amongst non-institutionalised children. The infection rate amongst subjects with Down's syndrome (DS) was higher than amongst subjects with other forms of
mental retardation
(OMR), and more than 95% of infections in both groups were unrecognised. By contrast with
hepatitis A
, hepatitis B virus was endemic in the institution with 81.2% of residents showing serological evidence of current or past infection. Of these, 40.8% of subjects with DS and 9.2% of those with OMR were found to be chronic carriers. The carrier rate was higher in males than females and tended to be more prolonged in subjects with DS. During the study period, the predominant subtype of HBsAg detected in the institution changed from adw to ayw.
...
PMID:A longitudinal study of hepatitis infection in an institution for the mentally retarded. 695 37